Global Molecular Biological Reagents Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Molecular Biological Reagents Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Molecular biology reagents provide researchers in academia and industry with consistent, robust, and accurate results. Molecular biology reagents are widely used to detect genetic material in cells and tissues. Examples include DNA and RNA analysis, gene expression, biochemical analysis, and protein export. They are also used in experiments or sample preparation, such as nucleic acid preparation, extraction, purification, and labeling of products.

Market Overview:

The latest research study on the global Molecular Biological Reagents market finds that the global Molecular Biological Reagents market reached a value of USD 10766.26 million in 2022. It’s expected that the market will achieve USD 16665.84 million by 2028, exhibiting a CAGR of 7.55% during the forecast period.

Increased burden of infectious and genetic disease

Molecular diagnostics play an important role in many areas of pathology, but their importance in infectious and genetic diseases cannot be underestimated. Thanks to the simplicity and widespread use of PCR, molecular techniques are now available for a variety of applications in routine clinical laboratories. Molecular diagnostic tools have the advantage of identifying specific organisms, and real-time PCR can quickly detect a variety of infectious microorganisms, providing high-quality nucleic acid extraction, sensitive detection, and accurate quantification, enabling laboratories to reduce costs and achieve better results. According to the World Health Organization, approximately 12,368 people tested positive for the influenza virus between January 24, 2022, and February 6, 2022. At the same time, according to the World Health Organization's 2021 report, Southeast Asia and Africa account for 43% and 25% of global TB cases, respectively. Sub-Saharan Africa is projected to bear the burden of malaria, accounting for approximately 95% of all malaria cases and 96% of all deaths. Hence, rising cases of infectious diseases will increase the demand for molecular biological reagents for diagnostic and therapeutic purposes, thereby driving the market growth. Furthermore, the rising number of babies with Down syndrome is expected to increase the demand for genetic testing, likewise driving market growth. For example, more than 6,000 babies with Down syndrome are born in the United States each year. Therefore, the increasing burden of infectious and genetic diseases will increase the market demand for molecular biological reagents.

Increase in Gene Sequencing

A few years ago, genome sequencing was limited to research facilities. However, it has now become one of the most commonly used techniques in clinical practice. Significant growth of the molecular biology reagents market is propelled by the significant reduction in the cost of genetic analysis leading to major developments in the fields of disease treatment, microbial genetics, and personalized medicine. Genetic information obtained through sequencing technologies contains massive datasets and confidential personal information. These genomic databases, when legally stored and processed, can help researchers understand the genetic basis of disease and its progression at the cellular level. R&D projects in the field of gene sequencing have increased the demand for molecular biotechnology tools such as enzymes and other proteins. The growing popularity of genome sequencing in the healthcare system has been supported by substantial investment from many governments. The UK, for example, announced the world's largest genome project as part of a $200m public-private partnership between charities and pharmaceutical companies. China has established the world's largest genome database through the 100,000-person plan, which aims to support researchers and industry through funding to combine data and real-world evidence obtained from the UK health service and create new products and services to improve efficiency and early Disease diagnosis. In response to the growing global demand for gene sequencing technology, molecular biology reagent companies are constantly developing and launching new products. For example, Jumpcode Genomics has launched the CRISPRclean Single Cell RNA Boost Kit. The technology removes uninformative sequences and improves single-cell experiments by providing better insights from genomic data. Therefore, the increase in gene sequencing activities is beneficial to the development of the molecular biology reagents industry.

Technological progress drives product innovation

Technological innovation has continuously promoted the development and progress of the life sciences field, and the increase in the types of molecular biology reagents has also promoted the expansion of downstream application fields. In 2022, Kaneka Corporation released the KANEKA RT-PCR Kit SARS-CoV-2 (Omicron/Delta) ver.2, a real-time PCR detection kit capable of simultaneously detecting Omicron (BA.1), Stealth Omicron (BA.2) and the Delta variant of COVID-19. The detection kit uses proprietary reagents developed by Kaneka Molecular Detection Technology to detect the presence of three variants with a single PCR test. This is expected to help reduce the burden of testing and facilitate the selection of the most appropriate drugs and treatments for each variant in the clinical setting. In March 2022, Illumina launched the TruSight Oncology (TSO) comprehensive in vitro genomic analysis kit, which evaluates multiple genes and biomarkers to reveal specific molecular signatures of cancer patients in Europe. This will help clinicians provide specific treatments to patients based on molecular profiles. In 2021 Genes2Me launched a Molecular Biology product range to accelerate and support bioscience research in India. The newly launched product range includes product categories such as Enzyme Technology, Cloning, Next Generation Sequencing, and Polymerase Chain Reaction. The expansion of application fields also contributes to expanding demand for biological reagents. For example, mRNA technology extends from the field of new crown vaccines to other fields such as tumor vaccines. The application of NGS technology in the fields of companion diagnosis and non-invasive prenatal diagnosis has been continuously enriched, which has generated a large demand for supporting biological reagents. All in all, with the development of new technologies in the field of life sciences, the scope of demand for corresponding supporting molecular biological reagents will continue to expand, and the market size of molecular biological reagents will also expand according.

Region Overview:

In 2021, the share of the Molecular Biological Reagents market in North America stood at 44.96%.

Company Overview:

Thermo Fisher, QIAGEN, Bio-Rad were the top 3 players in the Molecular Biological Reagents market in 2022, taking up a market share of 35.75% together.

Segmentation Overview:

By type, Enzyme segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Pharmaceutical & Biotechnology Companies segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Molecular Biological Reagents market covered in Chapter 3:

Bio-Rad
Thermo Fisher
Vazyme
New England Biolabs (NEB)
QIAGEN
TransGen Biotech
Genscript
CWBIO
Roche
ABclonal Technology
Promega Corporation
Yeasen Biotechnology
Takara

In Chapter 4 and Chapter 14.2, on the basis of types, the Molecular Biological Reagents market from 2018 to 2029 is primarily split into:

Enzyme
Nucleic Acid
Carrier
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Molecular Biological Reagents market from 2018 to 2029 covers:

College
Pharmaceutical Company
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)